Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Apple
AAPL
|
+$1.44B |
| 2 |
Microsoft
MSFT
|
+$1.16B |
| 3 |
Amazon
AMZN
|
+$797M |
| 4 |
Tesla
TSLA
|
+$537M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$441M |
Top Sells
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$199M |
| 2 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$191M |
| 3 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$62.8M |
| 4 |
Exelon
EXC
|
+$46.4M |
| 5 |
KL
Kirkland Lake Gold Ltd Ordinary
KL
|
+$43.9M |
Sector Composition
| 1 | Technology | 28.24% |
| 2 | Healthcare | 14.22% |
| 3 | Consumer Discretionary | 13.07% |
| 4 | Communication Services | 9.52% |
| 5 | Industrials | 8.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1976
CEVA Inc
CEVA
$549M
| $2.21M | ﹤0.01% |
54,400
+4,000
| +8% | +$163K |
|
1977
Sonic Automotive
SAH
$2.77B
| $2.21M | ﹤0.01% |
51,900
+3,000
| +6% | +$128K |
|
1978
Agilysys
AGYS
$3.03B
| $2.21M | ﹤0.01% |
55,300
+3,900
| +8% | +$156K |
|
1979
Enovix
ENVX
$1.74B
| $2.21M | ﹤0.01% |
176,571
+66,971
| +61% | +$836K |
|
1980
TFS Financial
TFSL
$3.76B
| $2.2M | ﹤0.01% |
132,800
+9,100
| +7% | +$151K |
|
1981
Astec Industries
ASTE
$1.06B
| $2.2M | ﹤0.01% |
51,200
+3,500
| +7% | +$151K |
|
1982
Usana Health Sciences
USNA
$551M
| $2.19M | ﹤0.01% |
27,600
+1,100
| +4% | +$87.4K |
|
1983
Fresh Del Monte Produce
FDP
$1.7B
| $2.19M | ﹤0.01% |
84,400
+6,100
| +8% | +$158K |
|
1984
Great Lakes Dredge & Dock
GLDD
$815M
| $2.18M | ﹤0.01% |
155,400
+10,300
| +7% | +$144K |
|
1985
James River Group
JRVR
$246M
| $2.18M | ﹤0.01% |
88,099
+5,700
| +7% | +$141K |
|
1986
National Healthcare
NHC
$1.76B
| $2.18M | ﹤0.01% |
31,030
+2,200
| +8% | +$154K |
|
|
NNDM
1987
Nano Dimension
NNDM
$319M
| $2.17M | ﹤0.01% |
609,900
+43,000
| +8% | +$153K |
|
1988
Utz Brands
UTZ
$1.12B
| $2.17M | ﹤0.01% |
146,700
+11,800
| +9% | +$174K |
|
1989
Pitney Bowes
PBI
$1.97B
| $2.17M | ﹤0.01% |
416,400
+28,600
| +7% | +$149K |
|
|
CSII
1990
DELISTED
Cardiovascular Systems, Inc.
CSII
| $2.17M | ﹤0.01% |
95,800
+7,200
| +8% | +$163K |
|
1991
Genesco
GCO
$365M
| $2.16M | ﹤0.01% |
34,000
+2,600
| +8% | +$165K |
|
1992
LeMaitre Vascular
LMAT
$2.13B
| $2.16M | ﹤0.01% |
46,500
+3,600
| +8% | +$167K |
|
1993
Perion Network
PERI
$415M
| $2.16M | ﹤0.01% |
93,670
+6,536
| +8% | +$151K |
|
1994
C3.ai
AI
$2.26B
| $2.16M | ﹤0.01% |
95,100
+6,700
| +8% | +$152K |
|
1995
Aspen Aerogels
ASPN
$560M
| $2.16M | ﹤0.01% |
62,600
+4,400
| +8% | +$152K |
|
1996
WideOpenWest
WOW
$440M
| $2.16M | ﹤0.01% |
123,600
+8,700
| +8% | +$152K |
|
1997
Washington Trust Bancorp
WASH
$570M
| $2.15M | ﹤0.01% |
41,000
+2,900
| +8% | +$152K |
|
1998
Kura Oncology
KURA
$766M
| $2.15M | ﹤0.01% |
133,700
+9,600
| +8% | +$154K |
|
1999
Castle Biosciences
CSTL
$665M
| $2.15M | ﹤0.01% |
47,900
+3,600
| +8% | +$162K |
|
2000
Denny's
DENN
$253M
| $2.15M | ﹤0.01% |
149,900
+8,100
| +6% | +$116K |
|